Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 1
2006 3
2007 9
2008 7
2009 6
2010 7
2011 7
2012 6
2013 6
2014 6
2015 5
2016 9
2017 7
2018 10
2019 18
2020 19
2021 9
2022 28
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

149 results
Results by year
Filters applied: . Clear all
Page 1
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N. Umemura S, et al. Among authors: ueda s. Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9. Hypertens Res. 2019. PMID: 31375757 Review. No abstract available.
Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE).
Tanaka A, Hisauchi I, Taguchi I, Sezai A, Toyoda S, Tomiyama H, Sata M, Ueda S, Oyama JI, Kitakaze M, Murohara T, Node K; CANDLE Trial Investigators. Tanaka A, et al. Among authors: ueda s. ESC Heart Fail. 2020 Aug;7(4):1585-1594. doi: 10.1002/ehf2.12707. Epub 2020 Apr 29. ESC Heart Fail. 2020. PMID: 32349193 Free PMC article. Clinical Trial.
Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Shoji T, Nakatani S, Kabata D, Mori K, Shintani A, Yoshida H, Takahashi K, Ota K, Fujii H, Ueda S, Nishi S, Nakatani T, Yoshiyama M, Goto K, Hamada T, Imanishi M, Ishimura E, Kagitani S, Kato Y, Kumeda Y, Maekawa K, Matsumura T, Nagayama H, Obi Y, Ohno Y, Sai Y, Sakurai M, Sasaki S, Shidara K, Shoji S, Tsujimoto Y, Yamakawa K, Yasuda H, Yodoi S, Inaba M, Emoto M. Shoji T, et al. Among authors: ueda s. Clin J Am Soc Nephrol. 2021 Apr 7;16(4):599-612. doi: 10.2215/CJN.16601020. Epub 2021 Mar 8. Clin J Am Soc Nephrol. 2021. PMID: 33685864 Free PMC article. Clinical Trial.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: ueda s. Clin Gastroenterol Hepatol. 2023 Feb;21(2):370-379. doi: 10.1016/j.cgh.2022.01.002. Epub 2022 Jan 17. Clin Gastroenterol Hepatol. 2023. PMID: 35051649
Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis.
Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, Eguchi K, Kamiyama K, Minematsu K, Ueda S, Rakugi H, Ohya Y, Kohro T, Yonemoto K, Okada Y, Higaki J, Tanahashi N, Kimura G, Umemura S, Matsumoto M, Shimamoto K, Ito S, Saruta T, Shimada K; Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group. Kitagawa K, et al. Among authors: ueda s. JAMA Neurol. 2019 Nov 1;76(11):1309-1318. doi: 10.1001/jamaneurol.2019.2167. JAMA Neurol. 2019. PMID: 31355878 Free PMC article.
Physiological Diagnostic Criteria for Vascular Failure.
Tanaka A, Tomiyama H, Maruhashi T, Matsuzawa Y, Miyoshi T, Kabutoya T, Kario K, Sugiyama S, Munakata M, Ito H, Ueda S, Vlachopoulos C, Higashi Y, Inoue T, Node K; Physiological Diagnosis Criteria for Vascular Failure Committee. Tanaka A, et al. Among authors: ueda s. Hypertension. 2018 Nov;72(5):1060-1071. doi: 10.1161/HYPERTENSIONAHA.118.11554. Hypertension. 2018. PMID: 30354826 Review. No abstract available.
Embedding Research Culture in Community Hospitals.
Iwata H, Kaneko M, Wakabayashi T, Ueda S. Iwata H, et al. Among authors: ueda s. Intern Med. 2022 Oct 15;61(20):3155. doi: 10.2169/internalmedicine.9338-22. Epub 2022 Feb 26. Intern Med. 2022. PMID: 35228436 Free PMC article. No abstract available.
Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysis.
Kitagawa K, Arima H, Yamamoto Y, Ueda S, Rakugi H, Kohro T, Yonemoto K, Matsumoto M, Saruta T, Shimada K; Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group. Kitagawa K, et al. Among authors: ueda s. Hypertens Res. 2022 Apr;45(4):591-601. doi: 10.1038/s41440-022-00862-y. Epub 2022 Mar 4. Hypertens Res. 2022. PMID: 35241817 Clinical Trial.
Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study.
Kusunose K, Yoshida H, Tanaka A, Teragawa H, Akasaki Y, Fukumoto Y, Eguchi K, Kamiya H, Kario K, Yamada H, Sata M, Node K; PRIZE Study Investigators. Kusunose K, et al. Hypertens Res. 2022 Jan;45(1):106-115. doi: 10.1038/s41440-021-00752-9. Epub 2021 Oct 17. Hypertens Res. 2022. PMID: 34657137 Free PMC article. Clinical Trial.
149 results